- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
LLS Targets Four Areas for Research
The Leukemia and Lymphoma Society hones in on four critical areas to be researched:
"The Leukemia & Lymphoma Society (LLS) is taking an aggressive approach to tackling the challenge of improving outcomes for patients with cancers that remain stubbornly resistant to treatment. As it has for more than 62 years, LLS will continue to accept applications from the world's best and brightest scientists to advance progress in all areas of blood cancer, and award grants based on merit. In addition LLS has identified four specific areas of need, and is soliciting applications from scientists and physicians who are working on these difficult problems.
"We are charting the course by identifying and prioritizing the areas of need and directing funding to research that shows the most promise for improving survival and quality of life for patients with these particular diseases," said Louis DeGennaro, Ph.D., LLS chief mission officer. "LLS wants to deliver better treatments, faster, to patients, and we have developed an innovative, strategic approach to achieve this goal.""